Milestone Scientific Inc. Commences Sales of CompuFlo® / CathCheck™ Disposables to the Nationally Recognized Medical Univ...
March 02 2021 - 9:30AM
Milestone Scientific Inc. (NYSE American:MLSS), a
leading developer of computerized drug delivery instruments that
provides virtually painless and precise injections, today announced
it has begun selling CompuFlo® / CathCheck™ disposables to the
Medical University of South Carolina (MUSC). The MUSC University
Medical Center is a nationally recognized and leading health
sciences university, recently ranked as the number one hospital in
South Carolina. MUSC Health owns and operates eight hospitals and
provides patient care throughout the state of South Carolina.
Arjan Haverhals, President of Milestone Scientific, further
noted, “We appreciate the support of Dr. Hebbar, Director
Obstetrics Anesthesia, and her team at MUSC. This latest commercial
order follows extensive testing on the part of the MUSC team. This
decision by another leading U.S. medical center further illustrates
the favorable response to both CathCheck and CompuFlo as we execute
on our goal to become the new standard of care in epidural
procedures.”
The clinical and safety benefits of the CompuFlo Epidural /
CathCheck System are backed by extensive published clinical data
demonstrating significant reductions in epidural punctures, as well
as complication rates, and contributes to savings of time on the
part of anesthesiologists. Moreover, the CompuFlo instrument has
the potential to significantly reduce costs associated with
morbidity, providing a direct economic benefit to healthcare
institutions. Similarly, the CathCheck technology has the potential
to transform the monitoring of catheter placement following an
epidural procedure by confirming the placement of a catheter within
2 minutes, versus 20-40 minutes using conventional methods.
About the Medical University of South Carolina
(MUSC)
Founded in 1824, the Medical University of South Carolina (MUSC)
continues the tradition of excellence in education, research and
patient care. MUSC educates and trains more than 3,000 students and
nearly 800 residents in six colleges and has more than 17,000
employees. As the state’s only integrated academic health sciences
center and largest non-federal employer in Charleston, the
university and its affiliates have collective annual budgets in
excess of $3.2 billion, with an annual economic impact of nearly $4
billion and annual research funding in excess of $284 million.
As the clinical health system of the Medical University of South
Carolina, MUSC Health is dedicated to delivering the highest
quality patient care available, while training generations of
competent, compassionate health care providers to serve the people
of South Carolina and beyond. Comprising some 1,600 beds, more than
100 outreach sites, the MUSC College of Medicine, the physicians’
practice plan, and nearly 275 telehealth locations, MUSC Health
owns and operates eight hospitals situated in Charleston, Chester,
Florence, Lancaster and Marion counties. In 2020, for the sixth
consecutive year, U.S. News & World Report named MUSC Health
the No. 1 hospital in South Carolina.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a biomedical
technology research and development company that patents, designs
and develops innovative diagnostic and therapeutic injection
technologies and instruments for medical, dental, cosmetic and
veterinary applications. Milestone's computer-controlled systems
are designed to make injections precise, efficient, and virtually
painless. Milestone’s proprietary DPS Dynamic Pressure Sensing
technology® is our technology platform that advances the
development of next-generation devices, regulating flow rate and
monitoring pressure from the tip of the needle, through platform
extensions for local anesthesia for subcutaneous drug delivery,
with specific applications for cosmetic botulinum toxin injections,
epidural space identification in regional anesthesia procedures and
intra-articular joint injections. For more information please visit
our website: www.milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking
statements regarding the timing and financial impact of Milestone's
ability to implement its business plan, expected revenues, timing
of regulatory approvals and future success. These statements
involve a number of risks and uncertainties and are based on
assumptions involving judgments with respect to future economic,
competitive and market conditions, future business decisions and
regulatory developments, all of which are difficult or impossible
to predict accurately and many of which are beyond Milestone's
control. Some of the important factors that could cause actual
results to differ materially from those indicated by the
forward-looking statements are general economic conditions, failure
to achieve expected revenue growth, changes in our operating
expenses, adverse patent rulings, FDA or legal developments,
competitive pressures, changes in customer and market requirements
and standards, and the risk factors detailed from time to time in
Milestone's periodic filings with the Securities and Exchange
Commission, including without limitation, Milestone's Annual Report
for the year ended December 31, 2019. The forward-looking
statements in this press release are based upon management's
reasonable belief as of the date hereof. Milestone undertakes no
obligation to revise or update publicly any forward-looking
statements for any reason.
Contact:David Waldman or
Natalya RudmanCrescendo Communications, LLCEmail:
mlss@crescendo-ir.comTel: 212-671-1020
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Apr 2023 to Apr 2024